Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-04-24

Clinical Trial Update: Liposomal Bupivacaine for Postoperative Pain Control in Urologic Procedures [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on liposomal bupivacaine for postoperative pain control in urologic procedures completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Liposomal bupivacaine (bupivacaine liposome injectable suspension)

Snippet

Sponsor: Loma Linda University | Conditions: Urinary Tract Diseases | Phase 4 | Status: COMPLETED | Results posted: 2024-04-24